Table 2 (abstract A113). Microbial isolations in blood, respiratory tract and urinary tract samples
From: Abstracts of the ICARE 2022 76th SIAARTI National Congress
Pre-pandemic (PP) | Intra-pandemic (IP) | ||
|---|---|---|---|
FAMILIES | n° (%) | n° (%) | FAMILIES |
Staphylococcus spp. | 23 (35.4%) | 37 (27.6%) | Staphylococcus spp. |
Enterobacteriaceae | 11 (16.9%) | 31 (23.1%) | Candida spp. § |
Pseudomonas aeruginosa | 10 (15.4%) | 15 (11.2%) | Enterobacteriaceae |
Others* | 6 (9.2%) | 12 (8.9%) | Enterococcus faecalis § |
Acinetobacter baumannii | 3 (4.6%) | 10 (7.5%) | Others* |
Morganella morganii | 3 (4.6%) | 9 (6.7%) | Pseudomonas aeruginosa |
Streptococcus spp. | 2 (3.1%) | 9 (6.7%) | Klebsiella spp. |
Stenotrophomonas maltophilia | 2 (3.1%) | 7 (5.2%) | Stenotrophomonas maltophilia |
Candida spp. | 2 (3.1%) | 2 (1.5%) | Streptococcus spp. |
Enterococcus faecalis | 1 (1.5%) | 1 (0.7%) | Acinetobacter baumannii |
Klebsiella spp. | 1 (1.5%) | 1 (0.7%) | Haemophilus influenzae |
Haemophilus influenzae | 1 (1.5%) | 0 (0%) | Morganella morganii |
Total number of isolated Microorganisms | 65 | 134 | Total number of isolated Microorganisms |